CTLA4 rs231775 may act as a risk factor for colorectal and thyroid cancers, while conversely serving as a protective factor against breast, liver, pancreatic and malt lymphoma [17,18,19,20]. This evidence concerns the gene CTLA4 and thyroid gland carcinoma.